FDA Grants KATE AI Breakthrough Device Designation for Early Sepsis Detection
The US FDA grants Breakthrough Device Designation for Mednition’s KATE Sepsis to expedite the review of novel breakthrough AI technology for sepsis KATE Sepsis is uniquely designed to enable the nursing workforce to recognize patients with sepsis in real-time KATE Sepsis improves early sepsis detection over standard of care by up to 118% BURLINGAME, Calif. …
FDA Grants KATE AI Breakthrough Device Designation for Early Sepsis Detection Read More »